Martin Schmidt Email

Chief Scientific Officer . Kypha

Current Roles

Employees:
32
Revenue:
$8M
About
Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
Kypha Address
4320 Forest Park Ave
Dublin, null
Kypha Email

Past Companies

KyphaChief Scientific Officer
KyphaDirector of Clinical Development
Washington University in St. LouisW.M. Keck Fellow in Molecular Medicine/Postdoctoral Research Associate

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.